China: Johnson & Johnson collaborates in China

Front row (left to right): Jian Chen, vice president, Xian Janssen Pharmaceuticals; Dan Wang, head, Johnson & Johnson Innovation, Asia Pacific; Sharona Tao, leader, communications & public affairs, Johnson & Johnson China; Jennifer Yang, head, Lung Cancer Initiative China, Johnson & Johnson Back row (left to right): Alex Zhavoronkov, founder & CEO, Insilico Medicine; Li Peng, assistant general manager, Taikang Online Insurance; Gary Ge, founder, Diannei

Johnson & Johnson Innovation has announced three new collaborations with strategic partners in China to address what it calls “areas of high unmet medical need across several areas”, including discovery science, lung cancer and medical devices. “These agreements span a diverse range of focus areas and represent a valuable opportunity to advance human health for…

You must be a HMI Subscriber to view this content.

Subscribe Now »